U.S. Markets open in 42 hrs, 29 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 14.7135 09:46 AM EDT | |
|---|---|---|
| Day High | 15.22 10:57 AM EDT |
|
| Range | 0.51 |
| Volume | 1.59 M | |
|---|---|---|
| 30-Day Avg Vol | 449,000 |
|
| Difference | 254.24% |
| Market Cap | 691.04 M | |
|---|---|---|
| Mkt Cap Chg | -7.37 M |
| Shares Out | 46.06 M | |
|---|---|---|
| % Shrs Traded | 3.45% | |
| 1yr EPS Est | -2.543 |
| 52-Wk Low | 8.66 1/15/09 | |
|---|---|---|
| 52-Wk High | 20.00 9/19/08 |
|
| Range | 11.34 |
| Prev Close | 15.16 7/1/09 | |
|---|---|---|
| Today's Open | 15.00 | |
| Change | -1.06% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.8 M |
| Revenue (LFY) | 48.15 M | |
|---|---|---|
| Earnings (LFY) | -97.74 M | |
| Earnings (MRQ) | -42.01 M | |
| Next Earn Est | -0.582 | |
| Next Earnings | 07/31/2009 |
|
| EPS (TTM) | -2.86 | |
| 1yr EPS Growth | 11.08% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -5.00 | |
| PEG Ratio | -0.33 | |
| Return on Equity | -180.70 | |
| Beta | 0.49 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
InterMune has found a good thing in interferon gamma. The company's sole marketed product is Actimmune (interferon gamma-1b), an FDA-approved treatment for two rare congenital disorders: chronic granulomatous ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.582 7/31/09 | — — |
—
—
|
| Last Quarter | -0.863 3/31/09 | -1.03 3/31/09 |
-0.167
Missed
|
| 2 Quarters Ago | -0.722 12/31/08 | -0.83 12/31/08 |
-0.108
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 6.85 M | 48.15 M |
| Gross Profit | 3.99 M | 39.16 M |
| Operating Income | -42.41 M | -95.68 M |
| Net Income | -42.01 M | -97.74 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts